DelSiTech And Bayer Partner To Develop Innovative Drug Delivery Technology For Ophthalmology
On the picture: CEO Lasse Leino, DelSiTech Ltd
DelSiTech Ltd, a Finnish drug delivery technology and drug development company, and Bayer have signed a Collaboration and Technology Licence Agreement for the worldwide application of DelSiTech’s Silica Matrix drug delivery platform to a number of Bayer’s compounds in ophthalmology. Read more.
DelSiTech Ltd., located in Turku, Finland, develops and commercializes its proprietary biodegradable silica based drug delivery technology. The Company collaborates with a number of pharma and biotech companies globally and works with its partners to turn their product ideas into novel drug products.
ScanBalt News
18 February 2019
Artur Travel new member of ScanBalt
